Xyclobutyl dihydroquinoline sulfonamit compound and pharmaceuticals containing this compound

Abstract

The invention proposes a compound of cyclobutyl dihydroquinoline sulfonamide with the formula enantiomer, non-enantiomer, rotational enantiomer of it, its compound, or its pharmaceutical salt, which inhibits electrochemical sodium channels, specifically Navl.7. The compounds are useful for the treatment of diseases related to the activity of sodium channels, for example. such as pain, cough, and asthma disorders. It is also proposed that preparations containing compounds according to the invention be developed. It is also proposed that selective atropine be prepared of the compounds with Formula (I) mentioned, and their intermediates.